scispace - formally typeset
D

Dieter Glatz

Researcher at University of Basel

Publications -  13
Citations -  421

Dieter Glatz is an academic researcher from University of Basel. The author has contributed to research in topics: Virtual microscopy & The Internet. The author has an hindex of 9, co-authored 13 publications receiving 407 citations.

Papers
More filters
Journal ArticleDOI

A multinational, internet-based assessment of observer variability in the diagnosis of serrated colorectal polyps

TL;DR: This Internet-based quiz suggests significant shortcomings in the routine H&E diagnosis of serrated colorectal polyps and suggests standardization of nomenclature, training of pathologists, and possibly development of ancillary techniques are of paramount importance for accurate patient management.
Journal ArticleDOI

An international telecytologic quiz on urinary cytology reveals educational deficits and absence of a commonly used classification system.

TL;DR: It is shown that large-scale international online quizzes may be used to find educational deficits in cytopathology and that 54.5% of all participants misclassified decoy cells as malignant.
Journal ArticleDOI

Factors to keep in mind when introducing virtual microscopy

TL;DR: An overview of the factors to keep in mind when introducing virtual microscopy is given and several commercially available virtual slide acquisition systems (VSAS) have been developed that use various technologies to acquire and distribute virtual slides.
Journal ArticleDOI

Virtual slides: high-quality demand, physical limitations, and affordability.

TL;DR: Physical and technical limitations of the VS technology are described to clarify the demands on a VS acquisition system and a new type of web-based VS viewer open to public use is introduced, allowing anyone to set up a VS system with high usability at low cost.
Journal ArticleDOI

Anatomic site-specific patterns of gene copy number gains in skin, mucosal, and uveal melanomas detected by fluorescence in situ hybridization

TL;DR: Site-specific genetic and epigenetic features may impact the response of melanomas to various anti-cancer drugs and should be considered in future studies on the molecular pathogenesis of malignant melanomas.